KYLA HALSOR: Open Payments
NPI 1225531098 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 12 payments from 9 companies in 2025. Trend: 2023 $260 · 2024 $754 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Nalu Medical, Inc. | 1 | $112 |
| Amgen Inc. | 1 | $83 |
| PFIZER INC. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: Nalu Neurostimulation System, Repatha, PAXLOVID, Sunosi, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, BREZTRI, Cologuard Collection Kit.
Industry payments across NM — which companies pay providers there.
